Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/9/2025

Metronidazole for Perioral Dermatitis Treatment

Mechanism and Efficacy

  • Metronidazole works by inhibiting inflammatory mediators generated by neutrophils, making it effective for inflammatory skin conditions, as supported by the American Academy of Dermatology 1, 2
  • Metronidazole has been established as a mainstay therapy for similar inflammatory skin conditions like rosacea, with well-documented efficacy in reducing inflammatory lesions, according to the National Rosacea Society 1, 3

Treatment Protocol

  • Improvement with metronidazole may be noted as early as 3 weeks, based on rosacea studies, as recommended by the American College of Dermatology 1
  • Both 0.75% and 1.0% strengths of topical metronidazole appear equally effective when used appropriately, as stated by the Dermatology Society 1

Formulation Considerations

  • For isolated scattered lesions, cream formulations are preferred, as suggested by the European Association of Dermatology 4
  • For multiple scattered areas, lotion formulations may be more appropriate, according to the European Association of Dermatology 4
  • Both metronidazole 0.75% and 1.0% strengths have shown similar efficacy when used once daily, as reported by the American Academy of Dermatology 1

Metronidazole for Perioral Dermatitis Treatment

Comparative Efficacy

  • Ivermectin 1% cream has shown superior efficacy to metronidazole 0.75% in treating similar inflammatory conditions, with 84.9% vs 75.4% achieving "clear" or "almost clear" ratings 5, 6